Related references
Note: Only part of the references are listed.Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
Christian Spurny et al.
PEDIATRIC BLOOD & CANCER (2018)
Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
Omer Kasalak et al.
SKELETAL RADIOLOGY (2018)
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets
Michaela C. Baldauf et al.
ONCOTARGET (2018)
Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, undifferentiated small round cell tumors. A clinicopathologic, immunophenotypic and molecular analysis
Isidro Machado et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2018)
Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas
Alberto S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma
Jennifer Worch et al.
PEDIATRIC BLOOD & CANCER (2018)
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)
Robin E. Norris et al.
PEDIATRIC BLOOD & CANCER (2018)
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Melina Heinemann et al.
PEDIATRIC BLOOD & CANCER (2018)
PRDM9 and Its Role in Genetic Recombination
Kenneth Paigen et al.
TRENDS IN GENETICS (2018)
CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
Maria Cristina Manara et al.
GENES (2018)
CD99 at the crossroads of physiology and pathology
Michela Pasello et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
Aparna Gorthi et al.
NATURE (2018)
EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma
F. Cidre-Aranaz et al.
ONCOGENE (2017)
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model
Tsion Zewdu Minas et al.
ONCOTARGET (2017)
ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair
Justin W. C. Leung et al.
GENES & DEVELOPMENT (2017)
Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma
Andrew S. Brohl et al.
GENETICS IN MEDICINE (2017)
Quality of Survivorship in a Rare Disease: Clinicofunctional Outcome and Physical Activity in an Observational Cohort Study of 618 Long-Term Survivors of Ewing Sarcoma
Andreas Ranft et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Orthotopic patient-derived xenografts of paediatric solid tumours
Elizabeth Stewart et al.
NATURE (2017)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C. Sheffield et al.
NATURE MEDICINE (2017)
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
G-A Franzetti et al.
ONCOGENE (2017)
EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma
A. M. Katschnig et al.
ONCOGENE (2017)
The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
M. Sechler et al.
ONCOGENE (2017)
Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth
Kirsten M. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma
Stefan K. Zoellner et al.
SCIENCE SIGNALING (2017)
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma
Stefan K. Zoellner et al.
SCIENCE SIGNALING (2017)
Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells
Uwe Thiel et al.
ONCOIMMUNOLOGY (2017)
A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome
Pauline Rochefort et al.
SCIENTIFIC REPORTS (2017)
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C. Harttrampf et al.
CLINICAL CANCER RESEARCH (2017)
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Gaylor Boulay et al.
CELL (2017)
Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?
Giuseppina Sannino et al.
CANCER RESEARCH (2017)
What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group-EWING1
Ricardo G. Becker et al.
BMC CANCER (2017)
Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases
Cristina R. Antonescu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH
Sonja Chen et al.
GENES CHROMOSOMES & CANCER (2016)
Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease
Jenny Potratz et al.
MOLECULAR ONCOLOGY (2016)
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
Tim Hensel et al.
ONCOTARGET (2016)
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States
Elisabeth A. Pedersen et al.
CANCER RESEARCH (2016)
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research
Wendy Chang et al.
CLINICAL CANCER RESEARCH (2016)
Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma
Manuela Krumbholz et al.
CLINICAL CANCER RESEARCH (2016)
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-EWING group
Stephanie Foulon et al.
EUROPEAN JOURNAL OF CANCER (2016)
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
Barbara C. Worst et al.
EUROPEAN JOURNAL OF CANCER (2016)
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases
Marco Gambarotti et al.
HISTOPATHOLOGY (2016)
Identifying barriers to oncologist referral to palliative care: A dual approach.
Kyle Whelan
JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Peter M. Anderson et al.
PEDIATRIC BLOOD & CANCER (2016)
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Tahereh Javaheri et al.
CELL DEATH & DISEASE (2016)
The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease
Heinrich Kovar et al.
ONCOTARGET (2016)
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
Laura Lagares-Tena et al.
ONCOTARGET (2016)
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma
Sudan N. Loganathan et al.
ONCOTARGET (2016)
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Emily R. Theisen et al.
ONCOTARGET (2016)
CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression
Marcella Martinelli et al.
ONCOTARGET (2016)
Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model
Aranzazu Villasante et al.
THERANOSTICS (2016)
Widespread Chromatin Accessibility at Repetitive Elements Links Stem Cells with Human Cancer
Nicholas C. Gomez et al.
CELL REPORTS (2016)
Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma
Kelly M. Bailey et al.
NEOPLASIA (2016)
Local Control in Ewing Sarcoma of the Chest Wall: Results of the EURO-EWING 99 Trial
Benedetta Bedetti et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Stress-mediated translational control in cancer cells
Gabriel Leprivier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells
Andrej Lissat et al.
BMC CANCER (2015)
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis
Amal M. El-Naggar et al.
CANCER CELL (2015)
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1
Syam Prakash Somasekharan et al.
JOURNAL OF CELL BIOLOGY (2015)
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway
Florian Engert et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2015)
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Thomas G. P. Gruenewald et al.
NATURE GENETICS (2015)
The Neurological Compromised Spine Due to Ewing Sarcoma. What First: Surgery or Chemotherapy? Therapy, Survival, and Neurological Outcome of 15 Cases With Primary Ewing Sarcoma of the Vertebral Column
Lida Mirzaei et al.
NEUROSURGERY (2015)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1
Algemir L. Brunetto et al.
PEDIATRIC BLOOD & CANCER (2015)
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Jose Luis Ordonez et al.
ONCOTARGET (2015)
Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
Eleni M. Tomazou et al.
CELL REPORTS (2015)
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
Cigall Kadoch et al.
SCIENCE ADVANCES (2015)
Regulation of gene transcription by Polycomb proteins
Sergi Aranda et al.
SCIENCE ADVANCES (2015)
Preclinical childhood sarcoma models: drug efficacy biomarker identification and validation
Brian Geier et al.
FRONTIERS IN ONCOLOGY (2015)
EWS/FLI1 target genes and therapeutic opportunities in Ewing sarcoma
Florencia Cidre-Aranaz et al.
FRONTIERS IN ONCOLOGY (2015)
Comparative Evaluation of Local Control Strategies in Localized Ewing Sarcoma of Bone A Report From the Children's Oncology Group
Steven G. DuBois et al.
CANCER (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Utility of Bone Marrow Aspiration and Biopsy in Initial Staging of Ewing Sarcoma
Lisa M. Kopp et al.
PEDIATRIC BLOOD & CANCER (2015)
Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour-stromal interactions: a report from the Children's Oncology Group
Samuel L. Volchenboum et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali et al.
ANNALS OF ONCOLOGY (2014)
Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Patients With Osteosarcoma
Michael Roth et al.
CANCER (2014)
Sarcoma Classification: An Update Based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone
Leona A. Doyle
CANCER (2014)
EWS-FLI-1 Regulates the Neuronal Repressor Gene REST, Which Controls Ewing Sarcoma Growth and Vascular Morphology
Zhichao Zhou et al.
CANCER (2014)
A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
CANCER (2014)
EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
Nicolo Riggi et al.
CANCER CELL (2014)
Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma
Jozef Ban et al.
CANCER RESEARCH (2014)
New Strategies in Ewing Sarcoma: Lost in Translation?
Fernanda I. Arnaldez et al.
CLINICAL CANCER RESEARCH (2014)
Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
Savita Sankar et al.
CLINICAL CANCER RESEARCH (2014)
Non-coding RNAs as direct and indirect modulators of epigenetic regulation
Veronica J. Peschansky et al.
EPIGENETICS (2014)
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis
Michelle Marques Howarth et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors
Miwa Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Time to Diagnosis of Ewing Tumors in Children and Adolescents Is Not Associated With Metastasis or Survival
Lorenzo Alonso et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma
Fariba Navid et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial
Marie-Cecile Le Deley et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors
Jason L. Hornick
MODERN PATHOLOGY (2014)
Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma
Aashi Chaturvedi et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Stress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma
Melanie A. Krook et al.
MOLECULAR CANCER RESEARCH (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Realizing the promise of cancer predisposition genes
Nazneen Rahman
NATURE (2014)
Phase 1 Trial of Temsirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents and Young Adults with Relapsed or Refractory Solid Tumors: A Children's Oncology Group Study
Rochelle Bagatell et al.
PEDIATRIC BLOOD & CANCER (2014)
The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma
Meybrit Rasper et al.
PEDIATRIC BLOOD & CANCER (2014)
The Genomic Landscape of Pediatric Ewing Sarcoma
Brian D. Crompton et al.
CANCER DISCOVERY (2014)
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
Franck Tirode et al.
CANCER DISCOVERY (2014)
Targeting the DNA Repair Pathway in Ewing Sarcoma
Elizabeth Stewart et al.
CELL REPORTS (2014)
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
Andrew S. Brohl et al.
PLOS GENETICS (2014)
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications
Isabella V. Miller et al.
BIOLOGY OF THE CELL (2013)
The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth
Thomas G. P. Grunewald et al.
BIOLOGY OF THE CELL (2013)
DKK2 Mediates Osteolysis, Invasiveness, and Metastatic Spread in Ewing Sarcoma
Kristina Hauer et al.
CANCER RESEARCH (2013)
ERBB4 confers metastatic capacity in Ewing sarcoma
Ariadna Mendoza-Naranjo et al.
EMBO MOLECULAR MEDICINE (2013)
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
Sven Bilke et al.
GENOME RESEARCH (2013)
G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1
Guenther H. S. Richter et al.
JOURNAL OF PATHOLOGY (2013)
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
S. Sankar et al.
ONCOGENE (2013)
An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing Sarcoma
Erik N. Newman et al.
PEDIATRIC BLOOD & CANCER (2013)
Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
Anna Raciborska et al.
PEDIATRIC BLOOD & CANCER (2013)
Ewing Sarcoma Cells Secrete EWS/Fli-1 Fusion mRNA via Microvesicles
Masanori Tsugita et al.
PLOS ONE (2013)
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
R. Luksch et al.
ANNALS OF ONCOLOGY (2012)
The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
S. Kailayangiri et al.
BRITISH JOURNAL OF CANCER (2012)
Late Effects of Chemotherapy and Radiotherapy in Osteosarcoma and Ewing Sarcoma Patients The Italian Sarcoma Group Experience (1983-2006)
Alessandra Longhi et al.
CANCER (2012)
A TARBP2-Dependent miRNA Expression Profile Underlies Cancer Stem Cell Properties and Provides Candlidate Therapeutic Reagents in Ewing Sarcoma
Claudio De Vito et al.
CANCER CELL (2012)
EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors
Christopher H. Evans et al.
CLINICAL CANCER RESEARCH (2012)
A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis
Stefanie W. Leacock et al.
DISEASE MODELS & MECHANISMS (2012)
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription
Mukund Patel et al.
GENOME RESEARCH (2012)
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Richard B. Womer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
Fumihiko Nakatani et al.
JOURNAL OF PATHOLOGY (2012)
STEAP1 Is Associated with the Invasive and Oxidative Stress Phenotype of Ewing Tumors
Thomas G. P. Grunewald et al.
MOLECULAR CANCER RESEARCH (2012)
Phase I Trial of bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell Vaccine (FANG) in Advanced Cancer
Neil Senzer et al.
MOLECULAR THERAPY (2012)
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
Sophie Postel-Vinay et al.
NATURE GENETICS (2012)
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Gaelle Pierron et al.
NATURE GENETICS (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
C. Mackintosh et al.
ONCOGENE (2012)
EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations
Robert Beck et al.
CANCER GENETICS (2012)
Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma
Toshifumi Fujiwara et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung
Zhichao Zhou et al.
ANGIOGENESIS (2011)
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
S. Ferrari et al.
ANNALS OF ONCOLOGY (2011)
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
U. Thiel et al.
ANNALS OF ONCOLOGY (2011)
Racial Differences in the Incidence of Mesenchymal Tumors Associated with EWSR1 Translocation
Jennifer Worch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
Heribert Juergens et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2011)
Specific Sites in the C Terminus of CTCF Interact with the SA2 Subunit of the Cohesin Complex and Are Required for Cohesin-Dependent Insulation Activity
Tiaojiang Xiao et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma
J. Ban et al.
ONCOGENE (2011)
Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells
Cornelia von Levetzow et al.
PLOS ONE (2011)
Risk of Recurrence and Survival After Relapse in Patients With Ewing Sarcoma
Martin Stahl et al.
PEDIATRIC BLOOD & CANCER (2011)
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
David A. Solomon et al.
SCIENCE (2011)
Promiscuous partnerships in Ewing's sarcoma
Savita Sankar et al.
CANCER GENETICS (2011)
Cancer biology and NuRD: a multifaceted chromatin remodelling complex
Anne Y. Lai et al.
NATURE REVIEWS CANCER (2011)
SIRT1-dependent regulation of chromatin and transcription: Linking NAD+ metabolism and signaling to the control of cellular functions
Tong Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway
S. Kamura et al.
BRITISH JOURNAL OF CANCER (2010)
The Value of Local Treatment in Patients With Primary, Disseminated, Multifocal Ewing Sarcoma (PDMES)
Julia Haeusler et al.
CANCER (2010)
Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
Guillaume A. Odri et al.
CANCER RESEARCH (2010)
Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro
Dave N. T. Aryee et al.
CANCER RESEARCH (2010)
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells
Nicolo Riggi et al.
GENES & DEVELOPMENT (2010)
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis
Anna Rocchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-EWING 99 Trial
Marie-Cecile Le Deley et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group
John A. van Doorninck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
Ruth Ladenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term Survivors of Childhood Ewing Sarcoma: Report From the Childhood Cancer Survivor Study
Jill P. Ginsberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Condensin and cohesin complexity: the expanding repertoire of functions
Andrew J. Wood et al.
NATURE REVIEWS GENETICS (2010)
Recent advances in the molecular pathogenesis of Ewing's sarcoma
E. C. Toomey et al.
ONCOGENE (2010)
Flow Cytometric Detection of Ewing Sarcoma Cells in Peripheral Blood and Bone Marrow
Steven G. DuBois et al.
PEDIATRIC BLOOD & CANCER (2010)
Ewing Sarcoma Demonstrates Racial Disparities in Incidence-related and Sex-related Differences in Outcome An Analysis of 1631 Cases From the SEER Database, 1973-2005
Muhammad U. Jawad et al.
CANCER (2009)
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Na Xu et al.
CELL (2009)
The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology
Karoly Szuhai et al.
CLINICAL CANCER RESEARCH (2009)
Molecular Diagnosis of Ewing Sarcoma Family of Tumors A Comparative Analysis of 560 Cases With FISH and RT-PCR
Isidro Machado et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2009)
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
Hayriye V. Erkizan et al.
NATURE MEDICINE (2009)
The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function (Publication with Expression of Concern. See vol. 17, 2022)
Noelle Guillon et al.
PLOS ONE (2009)
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
Guenther H. S. Richter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support
Antonio Llombart-Bosch et al.
VIRCHOWS ARCHIV (2009)
Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells
Annie Hurtubise et al.
Cancer Cell International (2008)
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma
Jozef Ban et al.
CANCER RESEARCH (2008)
BMI-1 promotes Ewing sarcoma tumorigenicity independent of CDKN2A repression
Dorothea Douglas et al.
CANCER RESEARCH (2008)
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells
Nicolo Riggi et al.
CANCER RESEARCH (2008)
EWS-FLI1 Induces Developmental Abnormalities and Accelerates Sarcoma Formation in a Transgenic Mouse Model
Patrick P. Lin et al.
CANCER RESEARCH (2008)
A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature
Jeffrey D. Hancock et al.
CELL CYCLE (2008)
Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: A study by the United Kingdom cancer cytogenetics and the children's cancer and leukaemia group
Paul Roberts et al.
GENES CHROMOSOMES & CANCER (2008)
Definitive radiotherapy for Ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity
Daniel J. Indelicato et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Microsatellites as EWIS/FLI response elements in Ewing's sarcoma
Kunal Gangwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation
John W. Edmunds et al.
EMBO JOURNAL (2008)
Positron emission tomography for staging of pediatric sarcoma patients:: Results of a prospective Multicenter trial
Thomas Voelker et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors
Hans U. Gerth et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells
Juergen Sonnemann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Chromatin crosstalk in development and disease: lessons from REST
Lezanne Ooi et al.
NATURE REVIEWS GENETICS (2007)
Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT
S. C. Brownhill et al.
BRITISH JOURNAL OF CANCER (2007)
A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP
Julia K. Pagan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mesenchymal stem cell features of Ewing tumors
Franck Tirode et al.
CANCER CELL (2007)
Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV
Tony L. Ng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: A study by the Societe Francaise des Cancers de l'Enfant
Odile Oberlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-EWING 99 clinical trial
Christine Juergens et al.
PEDIATRIC BLOOD & CANCER (2006)
JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor
Kenichi Yamane et al.
CELL (2006)
Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells
M Kreppel et al.
ONCOGENE (2006)
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells
N Riggi et al.
CANCER RESEARCH (2005)
Intercellular junctions in Ewing sarcoma/primitive neuroectodermal tumor: additional evidence of epithelial differentiation
AN Schuetz et al.
MODERN PATHOLOGY (2005)
Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, Ewing sarcoma-like tumors
CT Yeny et al.
CANCER RESEARCH (2005)
Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion:: A highly lethal subset associated with poor chemoresponse
HY Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets
MS Staege et al.
CANCER RESEARCH (2004)
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors:: Results of two consecutive regimens assessing the role of total-body irradiation
S Burdach et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells
A Üren et al.
ONCOGENE (2003)
Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation
AAP Zada et al.
ONCOGENE (2003)
Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
A Schuck et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor
G Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic impact of chromosomal aberrations in Ewing tumours
CM Hattinger et al.
BRITISH JOURNAL OF CANCER (2002)
Farm exposures, parental occupation, and risk of Ewing's sarcoma in Australia: a national case-control study
PC Valery et al.
CANCER CAUSES & CONTROL (2002)
Fractures in pediatric Ewing sarcoma
LM Wagner et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2001)
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors:: Comparison with spiral CT
C Franzius et al.
ANNALS OF ONCOLOGY (2001)
Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
M Paulussen et al.
ANNALS OF ONCOLOGY (2001)
A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells
L Girnita et al.
ONCOGENE (2000)
Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma
B Widhe et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2000)
Share Paper
